세계의 데옥시콜산 비만 치료제 시장 보고서(2025년)

Deoxycholic acid obesity drugs are pharmaceutical products containing deoxycholic acid, a naturally occurring bile acid, designed to break down and eliminate localized fat deposits. They are primarily used in non-surgical fat reduction procedures, targeting areas such as the chin, abdomen, and other resistant fat regions.

The primary types of deoxycholic acid obesity drugs include ATX-101 (deoxycholic acid injection, also known as Kybella or Belkyra), experimental or compounded deoxycholic acid formulations, combination therapies, and oral deoxycholic acid products. ATX-101 refers to the commercially approved injectable formulations used for targeted fat reduction. These drugs are available in several forms, including injectable and topical options, and are distributed through channels such as direct sales, retail pharmacies, and online pharmacies. Applications include submental fat reduction, abdominal fat reduction, thighs, arms, flanks, lipomas, localized fat, and cellulite management. Key end-users include aesthetic clinics, dermatology clinics, plastic surgery centers, hospitals, and medical administration facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The deoxycholic acid obesity drugs market research report is one of a series of new reports from The Business Research Company that provides deoxycholic acid obesity drugs market statistics, including deoxycholic acid obesity drugs industry global market size, regional shares, competitors with a deoxycholic acid obesity drugs market share, detailed deoxycholic acid obesity drugs market segments, market trends and opportunities, and any further data you may need to thrive in the deoxycholic acid obesity drugs industry. This deoxycholic acid obesity drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The deoxycholic acid obesity drug market size has grown rapidly in recent years. It will grow from $0.44 billion in 2024 to $0.50 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth during the historic period is attributed to the increasing preference for minimally invasive procedures, the rising number of aesthetic clinics and specialized treatment centers, growing consumer willingness to spend on cosmetic and obesity treatments, expanding clinical evidence supporting the efficacy and safety of deoxycholic acid injections, and increasing regulatory approvals and supportive policies in key markets.

The deoxycholic acid obesity drug market size is expected to see rapid growth in the next few years. It will grow to $0.85 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. The growth during the forecast period is driven by the rising prevalence of obesity, growing demand for non-surgical fat reduction treatments, increasing awareness of body aesthetics and cosmetic procedures, higher investment in research and development for new deoxycholic acid formulations, and expanding availability of high-purity and combination therapy products. Key trends in the forecast period include the development of combination therapies, innovations in medical technology and treatment protocols, advancements in formulation technologies, integration of digital tools and artificial intelligence for treatment planning, and improvements in injection lipolysis formulations.

The increasing obesity rates are expected to drive the growth of the deoxycholic acid obesity drug market in the coming years. Obesity rates refer to the proportion of individuals in a population who are classified as overweight or obese based on their body mass index. The rise in obesity is largely influenced by unhealthy dietary patterns, including high consumption of processed foods and sugary beverages, which contribute to excessive calorie intake and fat accumulation in the body. Deoxycholic acid obesity drugs aid in addressing this issue by breaking down and eliminating fat cells, which leads to targeted fat reduction and improved body contour. For example, in September 2023, the Centers for Disease Control and Prevention, a government agency based in the United States, reported that in 2022, twenty-two states had adult obesity rates of thirty-five percent or higher, compared to nineteen states in 2021. As a result, the rising obesity rates are contributing to the growth of the deoxycholic acid obesity drug market.

The increasing demand for non-surgical body contouring solutions is expected to support the growth of the deoxycholic acid obesity drug market in the years ahead. Non-surgical body contouring involves treatments that are either non-invasive or minimally invasive, using methods such as cryolipolysis, ultrasound, radiofrequency, or lasers to reduce fat, tighten skin, and reshape the body without surgical intervention. The popularity of these treatments is growing as more individuals opt for safer, less invasive alternatives to traditional cosmetic surgery. These procedures provide effective fat reduction and skin tightening with less discomfort, reduced risk, and little to no recovery time. Deoxycholic acid obesity drugs contribute to non-surgical body contouring by targeting and breaking down fat cells when injected into specific areas, resulting in the reduction of persistent fat deposits and improved body appearance without the need for surgery. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery, a professional organization based in the United States, reported that in 2023, botulinum toxin remained the most commonly performed non-surgical procedure across all age groups and genders, with eight point eight million treatments performed globally, while hyaluronic acid procedures increased by twenty-nine percent, reaching five point five million treatments. Therefore, the rising demand for non-surgical body contouring is contributing to the growth of the deoxycholic acid obesity drug market.

Leading companies in the deoxycholic acid obesity drug market are focusing on the development of advanced injectable solutions to enhance fat reduction outcomes and improve patient satisfaction. These injectable treatments use deoxycholic acid, a compound that dissolves fat cells, and are administered directly into targeted areas to achieve localized fat reduction. For instance, in March 2024, LG Chem Ltd., a chemicals company based in South Korea, launched Bellacholine for the treatment of submental fat. This non-surgical injection is designed to reduce moderate to severe fat under the chin by safely breaking down fat cells using deoxycholic acid. It features benefits such as a pH level compatible with the body, minimal sediment formation, and the ability to enhance skin elasticity through the stimulation of collagen production.

Major players in the deoxycholic acid obesity drugs market are AbbVie Inc., Cipla Ltd., Glenmark Life Sciences Limited, Curia Global Inc., Daewoong Pharmaceutical Co. Ltd., Actylis, ICE Pharma, Cayman Chemical Company, Nacalai Tesque Inc., Sichuan Huiyu Pharmaceutical, Conscientia Industrial, Manus Aktteva Biopharma LLP, Jeevan Chemicals & Pharmaceuticals, Anhui Chem-Bright Bioengineering Co. Ltd., GlpBio Technology LLC, Legere Pharmaceuticals, Otto Chemie Pvt. Ltd., BOC Sciences, Guangzhou Green Cross Pharmaceutical, Prodotti Chimici e Alimentari S.P.A.

North America was the largest region in the deoxycholic acid obesity drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in deoxycholic acid obesity drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the deoxycholic acid obesity drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The deoxycholic acid obesity drugs market consists of sales of injection lipolysis with bile acid derivatives, investigational and preclinical agents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Deoxycholic Acid Obesity Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on deoxycholic acid obesity drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for deoxycholic acid obesity drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The deoxycholic acid obesity drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: ATX-101 (Deoxycholic Acid Injection Or Kybella Or Belkyra); Experimental Or Compounded Deoxycholic Acid Formulations; Combination Therapies; Oral Deoxycholic Acid Products
• 2) By Formulation: Injectable; Topical
• 3) By Distribution Channel: Direct Sales; Retail Pharmacies; Online Pharmacies
• 4) By Application: Submental Fat Reduction; Abdominal Fat Reduction; Thighs Arms And Flanks; Lipomas And Localized Fat; Cellulite Management
• 5) By End-User: Aesthetic Clinics; Dermatology Clinics; Plastic Surgery Centers; Hospitals; Home Administration
• Subsegments:
• 1) By ATX-101 (Deoxycholic Acid Injection or Kybella or Belkyra): Standard Injectable; High-Purity Formulations; Combination Injection Therapies
• 2) By Experimental Or Compounded Deoxycholic Acid Formulation: Clinical Trial Formulations; Compounded Customized Formulations
• 3) By Combination Therapies: Deoxycholic Acid + Lipolytic Agents; Deoxycholic Acid + Enzyme Therapy
• 4) By Oral Deoxycholic Acid Products: Capsules; Tablets; Liquid Formulations
• Companies Mentioned: AbbVie Inc.; Cipla Ltd.; Glenmark Life Sciences Limited; Curia Global Inc.; Daewoong Pharmaceutical Co. Ltd.; Actylis; ICE Pharma; Cayman Chemical Company; Nacalai Tesque Inc.; Sichuan Huiyu Pharmaceutical; Conscientia Industrial; Manus Aktteva Biopharma LLP; Jeevan Chemicals & Pharmaceuticals; Anhui Chem-Bright Bioengineering Co. Ltd.; GlpBio Technology LLC; Legere Pharmaceuticals; Otto Chemie Pvt. Ltd.; BOC Sciences; Guangzhou Green Cross Pharmaceutical; Prodotti Chimici e Alimentari S.P.A
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Deoxycholic Acid Obesity Drugs Market Characteristics

3. Deoxycholic Acid Obesity Drugs Market Trends And Strategies

4. Deoxycholic Acid Obesity Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Deoxycholic Acid Obesity Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Deoxycholic Acid Obesity Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Deoxycholic Acid Obesity Drugs Market Growth Rate Analysis
• 5.4. Global Deoxycholic Acid Obesity Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Deoxycholic Acid Obesity Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Deoxycholic Acid Obesity Drugs Total Addressable Market (TAM)

6. Deoxycholic Acid Obesity Drugs Market Segmentation

• 6.1. Global Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ATX-101 (Deoxycholic Acid Injection Or Kybella Or Belkyra)
• Experimental Or Compounded Deoxycholic Acid Formulations
• Combination Therapies
• Oral Deoxycholic Acid Products
• 6.2. Global Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Topical
• 6.3. Global Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Sales
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Deoxycholic Acid Obesity Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Submental Fat Reduction
• Abdominal Fat Reduction
• Thighs Arms And Flanks
• Lipomas And Localized Fat
• Cellulite Management
• 6.5. Global Deoxycholic Acid Obesity Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aesthetic Clinics
• Dermatology Clinics
• Plastic Surgery Centers
• Hospitals
• Home Administration
• 6.6. Global Deoxycholic Acid Obesity Drugs Market, Sub-Segmentation Of ATX-101 (Deoxycholic Acid Injection or Kybella or Belkyra), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Injectable
• High-Purity Formulations
• Combination Injection Therapies
• 6.7. Global Deoxycholic Acid Obesity Drugs Market, Sub-Segmentation Of Experimental Or Compounded Deoxycholic Acid Formulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Trial Formulations
• Compounded Customized Formulations
• 6.8. Global Deoxycholic Acid Obesity Drugs Market, Sub-Segmentation Of Combination Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Deoxycholic Acid + Lipolytic Agents
• Deoxycholic Acid + Enzyme Therapy
• 6.9. Global Deoxycholic Acid Obesity Drugs Market, Sub-Segmentation Of Oral Deoxycholic Acid Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capsules
• Tablets
• Liquid Formulations

7. Deoxycholic Acid Obesity Drugs Market Regional And Country Analysis

• 7.1. Global Deoxycholic Acid Obesity Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Deoxycholic Acid Obesity Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Deoxycholic Acid Obesity Drugs Market

• 8.1. Asia-Pacific Deoxycholic Acid Obesity Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Deoxycholic Acid Obesity Drugs Market

• 9.1. China Deoxycholic Acid Obesity Drugs Market Overview
• 9.2. China Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Deoxycholic Acid Obesity Drugs Market

• 10.1. India Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Deoxycholic Acid Obesity Drugs Market

• 11.1. Japan Deoxycholic Acid Obesity Drugs Market Overview
• 11.2. Japan Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Deoxycholic Acid Obesity Drugs Market

• 12.1. Australia Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Deoxycholic Acid Obesity Drugs Market

• 13.1. Indonesia Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Deoxycholic Acid Obesity Drugs Market

• 14.1. South Korea Deoxycholic Acid Obesity Drugs Market Overview
• 14.2. South Korea Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Deoxycholic Acid Obesity Drugs Market

• 15.1. Western Europe Deoxycholic Acid Obesity Drugs Market Overview
• 15.2. Western Europe Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Deoxycholic Acid Obesity Drugs Market

• 16.1. UK Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Deoxycholic Acid Obesity Drugs Market

• 17.1. Germany Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Deoxycholic Acid Obesity Drugs Market

• 18.1. France Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Deoxycholic Acid Obesity Drugs Market

• 19.1. Italy Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Deoxycholic Acid Obesity Drugs Market

• 20.1. Spain Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Deoxycholic Acid Obesity Drugs Market

• 21.1. Eastern Europe Deoxycholic Acid Obesity Drugs Market Overview
• 21.2. Eastern Europe Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Deoxycholic Acid Obesity Drugs Market

• 22.1. Russia Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Deoxycholic Acid Obesity Drugs Market

• 23.1. North America Deoxycholic Acid Obesity Drugs Market Overview
• 23.2. North America Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Deoxycholic Acid Obesity Drugs Market

• 24.1. USA Deoxycholic Acid Obesity Drugs Market Overview
• 24.2. USA Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Deoxycholic Acid Obesity Drugs Market

• 25.1. Canada Deoxycholic Acid Obesity Drugs Market Overview
• 25.2. Canada Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Deoxycholic Acid Obesity Drugs Market

• 26.1. South America Deoxycholic Acid Obesity Drugs Market Overview
• 26.2. South America Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Deoxycholic Acid Obesity Drugs Market

• 27.1. Brazil Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Deoxycholic Acid Obesity Drugs Market

• 28.1. Middle East Deoxycholic Acid Obesity Drugs Market Overview
• 28.2. Middle East Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Deoxycholic Acid Obesity Drugs Market

• 29.1. Africa Deoxycholic Acid Obesity Drugs Market Overview
• 29.2. Africa Deoxycholic Acid Obesity Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Deoxycholic Acid Obesity Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Deoxycholic Acid Obesity Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Deoxycholic Acid Obesity Drugs Market Competitive Landscape And Company Profiles

• 30.1. Deoxycholic Acid Obesity Drugs Market Competitive Landscape
• 30.2. Deoxycholic Acid Obesity Drugs Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Cipla Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Glenmark Life Sciences Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Curia Global Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Daewoong Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Deoxycholic Acid Obesity Drugs Market Other Major And Innovative Companies

• 31.1. Actylis
• 31.2. ICE Pharma
• 31.3. Cayman Chemical Company
• 31.4. Nacalai Tesque Inc.
• 31.5. Sichuan Huiyu Pharmaceutical
• 31.6. Conscientia Industrial
• 31.7. Manus Aktteva Biopharma LLP
• 31.8. Jeevan Chemicals & Pharmaceuticals
• 31.9. Anhui Chem-Bright Bioengineering Co. Ltd.
• 31.10. GlpBio Technology LLC
• 31.11. Legere Pharmaceuticals
• 31.12. Otto Chemie Pvt. Ltd.
• 31.13. BOC Sciences
• 31.14. Guangzhou Green Cross Pharmaceutical
• 31.15. Prodotti Chimici e Alimentari S.P.A

32. Global Deoxycholic Acid Obesity Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Deoxycholic Acid Obesity Drugs Market

34. Recent Developments In The Deoxycholic Acid Obesity Drugs Market

35. Deoxycholic Acid Obesity Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Deoxycholic Acid Obesity Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Deoxycholic Acid Obesity Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Deoxycholic Acid Obesity Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer